Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 8:09 pm Sale |
2024-12-31 | 13G | Erasca, Inc. ERAS |
SUVRETTA CAPITAL MANAGEMENT, LLC | 12,315,004 4.400% |
-1,453,035 (-10.55%) |
Filing History |
| 2025-02-12 5:02 pm Unchanged |
2024-12-31 | 13G | Erasca, Inc. ERAS |
NOVARTIS INC | 12,307,692 4.400% |
0 (Unchanged) |
Filing History |
| 2024-11-14 5:13 pm Sale |
2024-05-21 | 13G | Erasca, Inc. ERAS |
ARCH Venture Fund X L.P. | 0 0.000% |
-11,055,554 (Position Closed) |
Filing History |
| 2024-11-14 4:04 pm Sale |
2024-09-30 | 13G | Erasca, Inc. ERAS |
Armistice Capital, LLC | 0 0.000% |
-8,096,000 (Position Closed) |
Filing History |
| 2024-11-14 1:28 pm Purchase |
2024-09-30 | 13G | Erasca, Inc. ERAS |
T. Rowe Price Investment Management, Inc. | 16,830,856 6.000% |
16,830,856 (New Position) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Erasca, Inc. ERAS |
BLACKROCK INC BLK |
15,358,280 5.400% |
0 (Unchanged) |
Filing History |
| 2024-10-29 8:28 pm Purchase |
2024-09-30 | 13G | Erasca, Inc. ERAS |
City Hill LLC | 33,902,800 11.900% |
776,724 (+2.34%) |
Filing History |
| 2024-10-24 2:02 pm Purchase |
2024-09-30 | 13G | Erasca, Inc. ERAS |
BLACKROCK INC BLK |
15,358,280 5.400% |
15,358,280 (New Position) |
Filing History |
| 2024-05-31 4:18 pm Purchase |
2024-05-21 | 13G | Erasca, Inc. ERAS |
Venrock Healthcare Capital Partners III L.P. | 16,216,216 6.500% |
16,216,216 (New Position) |
Filing History |
| 2024-05-29 11:55 am Purchase |
2024-05-21 | 13G | Erasca, Inc. ERAS |
Frazier Life Sciences Public Fund, L.P. | 16,216,216 5.900% |
16,216,216 (New Position) |
Filing History |
| 2024-05-28 4:34 pm Purchase |
2024-05-17 | 13G | Erasca, Inc. ERAS |
SUVRETTA CAPITAL MANAGEMENT, LLC | 13,768,039 5.500% |
13,768,039 (New Position) |
Filing History |
| 2024-02-14 3:36 pm Purchase |
2023-12-31 | 13G | Erasca, Inc. ERAS |
Armistice Capital, LLC | 8,096,000 5.360% |
8,096,000 (New Position) |
Filing History |
| 2024-02-13 8:24 pm Purchase |
2023-12-31 | 13G | Erasca, Inc. ERAS |
City Hill LLC | 33,126,076 21.800% |
2,832,750 (+9.35%) |
Filing History |
| 2024-01-30 4:41 pm Sale |
2023-11-29 | 13D | Erasca, Inc. ERAS |
Cormorant Asset Management LP | 0 0.000% |
-10,893,107 (Position Closed) |
Filing History |
| 2023-03-10 09:30 am Sale |
2023-03-09 | 13G | Erasca, Inc. ERAS |
FMR CORP | 1,078,970 0.783% |
-8,358,274 (-88.57%) |
Filing History |
| 2023-02-14 4:20 pm Sale |
2022-12-31 | 13G | Erasca, Inc. ERAS |
City Hill LLC | 30,293,326 24.700% |
-1,762,256 (-5.50%) |
Filing History |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | Erasca, Inc. ERAS |
PFM Health Sciences, LP | 4,797,460 3.200% |
-2,953,028 (-38.10%) |
Filing History |
| 2023-02-09 10:59 am Sale |
2023-02-09 | 13G | Erasca, Inc. ERAS |
FMR CORP | 9,437,244 6.853% |
-3,584,706 (-27.53%) |
Filing History |
| 2022-12-21 4:32 pm Purchase |
2022-12-13 | 13D | Erasca, Inc. ERAS |
Cormorant Asset Management LP | 10,893,107 7.260% |
387,554 (+3.69%) |
Filing History |
| 2022-12-19 4:21 pm Purchase |
2022-12-09 | 13G | Erasca, Inc. ERAS |
NOVARTIS INC | 12,307,692 8.200% |
12,307,692 (New Position) |
Filing History |